MedPath

The Effect of Adjunct Vitamin a on Community-Acquired Pneumonia in Southern Iranian Children: a Randomized Clinical Trial

Not Applicable
Completed
Conditions
Community-Acquired Pneumonia
Vitamin a
Registration Number
NCT06677684
Lead Sponsor
Hormozgan University of Medical Sciences
Brief Summary

This randomized clinical trial included 105 children with CAP who were admitted to Bandar Abbas Children's Hospital. Participants were randomly assigned to two groups: a control group receiving standard antibiotic therapy and an intervention group receiving standard antibiotics plus vitamin A (25,000 IU for 2 days). Key data collected included age, sex, duration of hospitalization, treatment duration, and daily Respiratory Index of Severity in Children (RISC) scores.

Detailed Description

Children to present with CAP symptoms

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
105
Inclusion Criteria
  • children to present with CAP symptoms, including fever, cough, pulmonary rales, respiratory distress (age-adjusted tachypnea: >50 breaths per minute for infants under 1 year, >40 for ages 1-5 years, and >30 for those over 5 years), and radiographic findings indicative of pneumonia.
Exclusion Criteria
  • underlying immunodeficiency, chronic respiratory conditions, concurrent use of immunosuppressive medications, prior high-dose vitamin A intake, and hospitalizations shorter than 24 hours

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
duration of hospitalizationKey data collected included age, sex, duration of hospitalization, treatment duration, and daily Respiratory Index of Severity in Children (RISC) scores.

Vitamin A supplementation was associated with a significant reduction in hospitalization duration in children with CAP, supporting its potential as an adjunct therapy.

Treatment duration daily Respiratory Index of Severity in Children (RISC) scoresFrom enrollment to the end of treatment and discharge of patients ( 6 months)

daily Respiratory Index of Severity in Children (RISC) scores

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hormozgan University of Medical Sciences

🇮🇷

Bandar Abbas, Hormozgan, Iran, Islamic Republic of

© Copyright 2025. All Rights Reserved by MedPath